Skip to main content
Premium Trial:

Request an Annual Quote

Challenge Trial Gets OK in UK

The UK has approved a trial in which volunteers will deliberately be exposed to SARS-CoV-2 to better understand how the virus infects people, Reuters reports.

The UK announced in October that it was investing £33.6 million (US $43.5 million) in the study — which will be conducted by Imperial College London, the Royal Free London NHS Foundation Trust, and the lab and clinical trial services company hVivo — despite critics arguing that deliberately exposing people to a potentially deadly disease is unethical. 

As Reuters reports, the trial is to begin within the month and will expose 90 healthy volunteers to small amounts of the original strain of the virus to determine how much of a dose is needed for an infection. The participants will be closely monitored and quarantined for 14 days at the Royal Free Hospital, it adds. 

"These human challenge studies will take place here in the UK and will help accelerate scientists' knowledge of how coronavirus affects people and could eventually further the rapid development of vaccines," Kwasi Kwarteng, the UK business secretary says, according to the Guardian.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.